Webinar: Calprotectin in infections

11. May 2022 | 3 min read

Webinar: Calprotectin in infections

Webinar: Calprotectin in infections

The webinar “Calprotectin in infections” looks into calprotectin’s role in infections. The webinar takes you through a quick introduction to the protein and biomarker calprotectin, followed by a summary of studies highlighting calprotectin in diagnosis and prognostics, as well as calprotectin in localised infections:

  • The biomarker calprotectin
  • Calprotectin as diagnostic marker in infections
  • Calprotectin as prognostic and risk marker
  • Calprotectin in localised infections

Watch the webinar now

 

 

GCAL® - Plasma and serum calprotectin immunoassay

The Gentian Calprotectin Immunoassay (GCAL®) is the first turbidimetric assay for the quantitative measurement of calprotectin in plasma and serum intended as an aid in the detection and assessment of inflammation. The open channel assay can be applied on a wide range of automated clinical chemistry analysers.

  • CE-marked and IVDR certified
  • Developed and manufactured by Gentian
  • Manufactured according to ISO 13485:2016


blood calprotectin

 

Get in touch for information and ordering

Interested in calprotectin for plasma and serum? Want to know more? Please send an email to marketing@gentian.com or fill out the form below:

 

 

New call-to-action

 




 

You may also read


Cystatin C testing - Balancing additional costs against potential benefits

Apr 11, 2024

Cystatin C testing - Balancing additional costs against potential benefits

The KDIGO (Kidney Disease: Improving Global Outcomes) 2024 Clinical Practice Guideline for the Evaluation and..

Scientists to Gentian’s R&D department

Apr 08, 2024

Scientists to Gentian’s R&D department

Scientists to Gentian’s application validation group We are looking for two new colleagues in the positions..

KDIGO CKD 2024 guidelines: Patients benefiting from combined cystatin C and creatinine

Apr 03, 2024

KDIGO CKD 2024 guidelines: Patients benefiting from combined cystatin C and creatinine

The global non-profit organisation KDIGO (Kidney Disease: Improving Global Outcomes), commits to create and..